Myeloproliferative neoplasms trials in Croatia
3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingResearch participation
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
- Where
- Grad Zagreb, Rijeka, Šibenik, Split, Zagreb
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Kartos Therapeutics Inc.
See details and how to join2023-504724-25-00EU 2023-504724-25-00Registry updated 2026-09-14
Phase 3RecruitingTrial-stage medicine
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Grad Zagreb, Rijeka, Šibenik
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672EU 2022-502276-23-00Registry updated 2026-03-25
Phase 3RecruitingTrial-stage medicine
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Where
- Rijeka, Šibenik, Split, Zagreb
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT06479135Registry updated 2025-09-25
All Myeloproliferative neoplasms trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.